isoflurophate has been researched along with Scleroderma, Systemic in 1 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solov'eva, NI | 1 |
| Volkova, ZI | 1 |
| Shcherbakov, AB | 1 |
1 other study available for isoflurophate and Scleroderma, Systemic
| Article | Year |
|---|---|
[The total proteolytic and collagenolytic activity in the blood cells of patients with systemic scleroderma].
Topics: Adult; Blood Cells; Chloromercuribenzoates; Chronic Disease; Edetic Acid; Female; Humans; Isofluroph | 1991 |